Blog Teasers no sidebar

As of April 2025, the Food & Drug Administration (FDA) has approved a medication called Dupixent for the treatment of chronic spontaneous urticaria. This biologic drug, generically known as dupilumab, ...

Read more

Generic and biosimilar products have long offered a more affordable alternative to brand-name medications. For many people, these options are the only way they can receive the prescriptions they need ...

Read more

The Trump administration has had a significant impact on many industries, including drug development. A primary focus has been on reducing drug prices, and a variety of strategies aim to ...

Read more

The drug approval process is a lengthy one that can take anywhere from months to years, but as the COVID-19 pandemic proved, it’s not always possible to wait that long ...

Read more

Orphan drugs are medications created to prevent, diagnose, and treat rare diseases. According to the National Institutes of Health, rare diseases are those that affect about five in 10,000 people. ...

Read more